Global Biomarkers Market Is Expected To Reach $237.15 Billion By 2032

Zion Market Research has published a new report titled “Biomarkers Market By Biomarker Type (Safety, Efficacy, and Validation), By Application (Diagnostic, Drug Discovery & Development, Personalized Medicine, and Others), and By Disease (Cancer, Cardiovascular Diseases, Neurological Diseases, Immunological Diseases, and Others), And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2024 – 2032”. According to the report, the global biomarkers market was USD 67.41 billion in 2023 and is predicted to grow to around USD 237.15 billion by 2032 with a compound annual growth rate (CAGR) of roughly 15.00% between 2024 and 2032.

A biomarker is a substance that can be introduced among organisms to inspect organ functions or other aspects of their health. A biomarker is objectively evaluated and measured as an indication of typical pathogenic processes, biological processes, or pharmacologic responses to therapeutic interventions. Biomarkers indicate a wide range of diseases or health characteristics along with the type or level of exposure to an environmental factor, genetic responses, genetic susceptibility to environmental exposure, markers of clinical or subclinical diseases, and indicators of response to therapy.

Browse the full “Biomarkers Market By Biomarker Type (Safety, Efficacy, and Validation), By Application (Diagnostic, Drug Discovery & Development, Personalized Medicine, and Others), and By Disease (Cancer, Cardiovascular Diseases, Neurological Diseases, Immunological Diseases, and Others), And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2024 – 2032” Report at https://www.zionmarketresearch.com/report/biomarkers-market

The global cancer biomarkers market is fragmented based on biomarker type, application, and disease. Based on biomarker type, the biomarkers market is categorized into safety, validation, and efficacy biomarkers. Safety biomarkers accounted for the highest market share in 2018, due to the increasing product adoption in drug discovery and development. Moreover, they are used in trials for preclinical studies to select drug candidates probable to be well-tolerated by individuals, which helps in decreasing cost and time for evaluation of drug development and preclinical safety.

Based on application, the biomarkers market includes personalized medicine, diagnostic, drug discovery and development, and others. Drug discovery and development accounted for a major market share in 2018. Biomarkers affect the major market players’ decision regarding whether to continue with the later phases of clinical developments. Additionally, pharmaceutical giants are undertaking an increasing number of R&D initiatives to develop targeted therapeutics.
 
By disease, the biomarkers market comprises immunological diseases, cancer, neurological diseases, cardiovascular diseases, and others. The cancer segment dominates the global biomarkers market, due to the growing demand for accurate and rapid diagnostic tools and rising cancer incidences globally. According to the National Cancer Institute, about 268,670 new cases of breast cancer were recorded in 2018 in the U.S.

North America dominated the biomarkers market globally in 2018 and is likely to remain dominant over the forecast time period as well. This regional dominance can be attributed to the regional presence of major pharmaceutical and biotechnology companies, increasing adoption of the latest technologies, and established healthcare infrastructure in North America. In terms of rate of growth, the Asia Pacific region is expected to record high growth in the biomarkers market globally in the years ahead.

The growing support of the regional governments for drug discovery and development programs and large patient pool are the major factors boosting the biomarkers market development in the Asia Pacific.

Biomarkers Market: Competitive Analysis

The global biomarkers market is led by players like:

• Agilent Technologies
• F. Hoffmann-La Roche
• Epigenomics
• Abbott
• Thermo Fisher Scientific
• Johnson & Johnson
• Siemens Healthcare
• Bio-Rad Laboratories
• Qiagen

This report segments the global biomarkers market into:

Global Biomarkers Market: Biomarker Type Analysis

• Safety Biomarkers
• Efficacy Biomarkers
• Validation Biomarkers

Global Biomarkers Market: Application Analysis

• Diagnostic
• Drug Discovery and Development
• Personalized Medicine
• Others

Global Biomarkers Market: Technology Analysis

• Cancer
• Cardiovascular Diseases
• Neurological Diseases
• Immunological Diseases
• Others

Global Biomarkers Market: Regional Analysis

• North America
  • The U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• The Middle East and Africa

About Us:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com